SOX2 and nasopharyngeal carcinoma: Due to the presence of these SGS‐associated signatures, we profiled the expression of the proliferative NPC marker Sox2 and found exclusive expression in S858R astrocytes, suggesting they may have a disease‐specific proliferative NPC‐like population (Figure 2E, Appendix S2).10, 47